BDX stock: buy or sell?
August 19th, 2019
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.
Should I buy BDX stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading strategy that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Becton, Dickinson and stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Becton, Dickinson and stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we gathered 13 ratings published for BDX stock in the last month. The general sentiment of these ratings is bullish for BDX stock, with 6 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-6||Piper Jaffray Companies||n/a||Overweight|
|2019-7-16||Morgan Stanley||n/a||Equal Weight|
|2019-5-13||Wells Fargo & Co||n/a||Outperform|
|2019-5-10||Morgan Stanley||n/a||Equal Weight|
|2019-4-15||Barclays||Equal Weight||Equal Weight|
|2019-2-5||Piper Jaffray Companies||n/a||Overweight|
|2019-1-2||Morgan Stanley||Equal Weight||Equal Weight|
BDX stock analysis
Becton, Dickinson and ended today at $251.48 and appreciated a good 1.27%.
Shares of Becton, Dickinson and closed today at $251.48 and appreciated a good 1.27%. Since price and SMA200d lines crossed up on Aug 6th, BDX climbed $15.14 (6.41%). Since last June when SMA100d and SMA200d crossed up, BDX price gained $12.89 per share (5.40%).
Shares of Becton, Dickinson and stepped up a slightly good 1.27% this week.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $258.06 resistance. Since price and SMA40w lines crossed up by mid June, BDX climbed $17.32 (7.40%). Late May, SMA20w and SMA40w crossed up triggering a rise of 10.48%. Far behind is the all-time high Becton, Dickinson and hit early October but price is just -4.51% below that top.
BDX stock price history
BDX stock historical price chart
BDX stock reached all-time highs on October with a price of $263.35.
BDX stock price target is $263.40Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' BDX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we found 13 price predictions for Becton, Dickinson and stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-6||Piper Jaffray Companies||Reiterates||$267.00||$266.00||-0.4%|
|2019-7-16||Morgan Stanley||Raises Target||$250.00||$261.00||4.4%|
|2019-6-28||Raymond James||Raises Target||$265.00||$288.00||8.7%|
|2019-5-13||Wells Fargo & Co||Reiterates||$280.00||$265.00||-5.4%|
|2019-5-10||UBS Group||Lowers Target||$265.00||$250.00||-5.7%|
|2019-5-10||Morgan Stanley||Lowers Target||$255.00||$250.00||-2%|
|2019-3-19||Raymond James||Lowers Target||$290.00||$280.00||-3.4%|
|2019-2-5||Piper Jaffray Companies||Raises Target||n/a||$274.00||-|
|2019-1-2||Morgan Stanley||Lowers Target||$265.00||$240.00||-9.4%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Becton, Dickinson and reported its latest financial data, close to analysts' consensus and published a $2.70 Earnings per Share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Becton, Dickinson and annual revenues rocketed an astounding 32.17% to $15,983.00 M dollars from $12,093.00 marked in 2017. Nevertheless, its earnings margin (compared to revenues) fell to 1.95%, that is $311.00 million. To have an updated view of the financial situation of Becton, Dickinson and, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q4 that can be compared to 2018 fiscal year results. Annual Becton, Dickinson and TTM sales up to December 2018 were $17,062.00 and earnings were $1,046.00 M dollars. If we compare this TTM figures with the last reported annuality, we can review Becton, Dickinson and business evolution since September 2018: Annual revenues up to December, compared to lastest yearly report, rose a shining 6.75%. Regarding profit margin, Becton, Dickinson and inched 4.18% to 1.95%
|2013||$8,050 M||-||$929 M11.5%||-|
|2014||$8,446 M||4.92%||$1,185 M14.0%||27.56%|
|2015||$10,282 M||21.74%||$695 M6.8%||-41.35%|
|2016||$12,483 M||21.41%||$976 M7.8%||40.43%|
|2017||$12,093 M||-3.12%||$1,100 M9.1%||12.70%|
|2018||$15,983 M||32.17%||$311 M1.9%||-71.73%|
|TTM||$17,062 M||6.75%||$1,046 M6.1%||236.33%|
Quarterly financial resultsBecton, Dickinson and reported $4,160.00 million in sales for 2018-Q4, a -5.50% decline compared to previous quarter. Reported quarter income marked $599.00 million with a profit margin of 14.40%. Profit margin climbed a 17.47% compared to previous quarter when profit margin was -3.07%. When comparing turnover to same quarter last year, Becton, Dickinson and sales marked an outstanding growth and boosted a 35.06%.
|2017-Q1||$2,970 M||-||$344 M11.6%||-|
|2017-Q2||$3,040 M||2.36%||$-132 M-4.3%||-138.37%|
|2017-Q3||$3,166 M||4.14%||$327 M10.3%||-347.73%|
|2017-Q4||$3,080 M||-2.72%||$-136 M-4.4%||-141.59%|
|2018-Q1||$4,222 M||37.08%||$-12 M-0.3%||-91.18%|
|2018-Q2||$4,278 M||1.33%||$594 M13.9%||-5,050.00%|
|2018-Q3||$4,402 M||2.90%||$-135 M-3.1%||-122.73%|
|2018-Q4||$4,160 M||-5.50%||$599 M14.4%||-543.70%|
Becton, Dickinson and ownershipWhen you are planning to buy a stock, it's worth to review its ownership structure.
Becton, Dickinson and shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.26% of all shares.
Bearish positions for BDX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Becton, Dickinson and:
|Market cap||$67.8 B||$44.4 B||$8.1 B||$93.1 M||$13.5 B|
|Total shares||269.7 M||510.2 M||24.7 M||37.7 M||268.1 M|
|Float shares||269.1 M||509.5 M||21.3 M||28.5 M||266.1 M|
|- Institutional holdings (%)||87.5%||88.2%||78.0%||74.1%||99.7%|
|- Insider holdings (%)||0.3%||0.1%||14.6%||12.9%||0.3%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Monday, August 19th, 2019|
|Day range||$249.43 - $252.69|
|Average true range||$7.07|
|50d mov avg||$248.81|
|100d mov avg||$242.69|
|200d mov avg||$240.22|
Becton, Dickinson and performanceTo better understand Becton, Dickinson and performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare Becton, Dickinson and to Baxter International, Bio-Rad Laboratories, Harvard Bioscience, Hologic, Intuitive Surgical, ResMed, Teleflex, Thermo Fisher Scientific, Varian Medical Systems and DENTSPLY SIRONA:
|TMOThermo Fisher Sci...||5.58%||9.52%||20.40%|
|VARVarian Medical Sy...||-16.61%||-17.92%||-2.03%|